Benzinga's Top Initiations

Analysts at Goldman Sachs initiated coverage on shares of Verisk Analytics VRSK with a “neutral” rating. The target price for Verisk Analytics is set to $68. Verisk Analytics' shares closed at $66.39 yesterday. JP Morgan initiated coverage on shares of NPS Pharmaceuticals NPSP with an “overweight” rating. The target price for NPS Pharmaceuticals is set to $40. NPS Pharmaceuticals' shares closed at $29.01 yesterday. Credit Suisse initiated coverage on shares of Macerich Company (The) MAC with an “underperform” rating. The target price for Macerich Company is set to $58. Macerich's stock closed at $59.61 yesterday. Analysts at Citigroup initiated coverage on shares of Clovis Oncology CLVS with a “buy” rating. The target price for Clovis Oncology is set to $109. Clovis Oncology's shares closed at $75.23 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsFinancialsRetail REIT'sTop Initiations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!